- Home
- Publications
- Publication Search
- Publication Details
Title
Pediatric AML: From Biology to Clinical Management
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 4, Issue 1, Pages 127-149
Publisher
MDPI AG
Online
2015-01-09
DOI
10.3390/jcm4010127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML
- (2014) C Anthias et al. BONE MARROW TRANSPLANTATION
- Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
- (2014) J R Passweg et al. BONE MARROW TRANSPLANTATION
- Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse
- (2014) Costa Bachas et al. BRITISH JOURNAL OF HAEMATOLOGY
- A critical review of which children with acute myeloid leukaemia need stem cell procedures
- (2014) Henrik Hasle BRITISH JOURNAL OF HAEMATOLOGY
- AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
- (2014) Todd M. Cooper et al. CANCER
- Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation
- (2014) Mariana Bastos-Oreiro et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
- (2014) U. Creutzig et al. HAEMATOLOGICA
- Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia
- (2014) D. G. Valerio et al. HAEMATOLOGICA
- Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
- (2014) Sarah M. Leonard et al. PLoS One
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- (2014) Chong Sun et al. Cell Reports
- RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells
- (2014) Simona Lamba et al. Cell Reports
- Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
- (2013) A. Pession et al. BLOOD
- Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004
- (2013) U. Creutzig et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults
- (2013) Christine L. Phillips et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes
- (2013) Yun-Gyoo Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia
- (2013) Carol O'Hear et al. CANCER
- Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006–2010): based on registry data from the Japanese Society of Pediatric Hematology
- (2013) Keizo Horibe et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium
- (2013) C. Michel Zwaan et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
- (2013) Gertjan J.L. Kaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of a Curative Treatment within the AML-BFM Studies
- (2013) U. Creutzig et al. KLINISCHE PADIATRIE
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
- (2013) J D E de Rooij et al. LEUKEMIA
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia
- (2013) Neerav Shukla et al. PEDIATRIC BLOOD & CANCER
- Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group
- (2013) Donna L. Johnston et al. PEDIATRIC BLOOD & CANCER
- Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation
- (2013) Michael J. Kelly et al. PEDIATRIC BLOOD & CANCER
- Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome
- (2013) Kalliopi N. Manola et al. Cancer Genetics
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
- (2012) H. Hasle et al. BLOOD
- Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study
- (2012) Toshihiko Imamura et al. BRITISH JOURNAL OF HAEMATOLOGY
- The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML
- (2012) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
- (2012) Catherine C. Smith et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study
- (2011) E. A. Coenen et al. BLOOD
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
- (2011) N. Hijiya et al. BLOOD
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
- (2011) M. Levis et al. BLOOD
- NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
- (2011) I. H. I. M. Hollink et al. BLOOD
- Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial
- (2011) Brenda E. S. Gibson et al. BRITISH JOURNAL OF HAEMATOLOGY
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
- (2011) B. V. Balgobind et al. HAEMATOLOGICA
- Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
- (2011) Daniel C. Link JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia
- (2011) Hiroto Inaba et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Low frequency of DNMT3A mutations in pediatric AML and the identification of the OCI-AML3 cell line as an in vitro model
- (2011) I H I M Hollink et al. LEUKEMIA
- Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
- (2011) Christopher N Hahn et al. NATURE GENETICS
- Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
- (2011) Xiao-Jing Yan et al. NATURE GENETICS
- Genetic and epigenetic similarities and differences between childhood and adult AML
- (2011) Caroline Juhl-Christensen et al. PEDIATRIC BLOOD & CANCER
- Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia
- (2011) Tanya C. Watt et al. PEDIATRIC BLOOD & CANCER
- Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene
- (2011) Lurdes Torres et al. PEDIATRIC BLOOD & CANCER
- Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
- (2011) Astrid A. Danen-van Oorschot et al. PEDIATRIC BLOOD & CANCER
- Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis
- (2011) Alix E. Seif Cancer Genetics
- High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)
- (2010) J. E. Kuipers et al. BLOOD
- A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia
- (2010) D. Niewerth et al. BLOOD
- High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine
- (2010) C. Bachas et al. BLOOD
- Mechanisms of leukemogenesis by MLL fusion proteins
- (2010) Rolf Marschalek BRITISH JOURNAL OF HAEMATOLOGY
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
- (2010) B. V. Balgobind et al. HAEMATOLOGICA
- Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
- (2010) I. H. I. M. Hollink et al. HAEMATOLOGICA
- HighEVI1Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
- (2010) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
- (2010) Christine von Neuhoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
- (2010) Christine J. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate
- (2010) Jonas Abrahamsson et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- TET2 mutations in childhood leukemia
- (2010) S M C Langemeijer et al. LEUKEMIA
- Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
- (2010) V H J van der Velden et al. LEUKEMIA
- EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
- (2010) B V Balgobind et al. LEUKEMIA
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study
- (2010) P A Ho et al. LEUKEMIA
- High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome
- (2010) B V Balgobind et al. LEUKEMIA
- Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials
- (2010) A Sander et al. LEUKEMIA
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options
- (2009) D. J. P. M. Stumpel et al. BLOOD
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
- (2009) I. H. I. M. Hollink et al. BLOOD
- AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
- (2009) P. P. Zarrinkar et al. BLOOD
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- (2009) B. V. Balgobind et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
- (2009) Christian M. Zwaan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): The incidence and correlation of a HLXB9 overexpression
- (2009) Joonhong Park et al. CANCER GENETICS AND CYTOGENETICS
- Circos: An information aesthetic for comparative genomics
- (2009) M. Krzywinski et al. GENOME RESEARCH
- Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
- (2009) Sima Jeha et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group
- (2009) Ichiro Tsukimoto et al. JOURNAL OF CLINICAL ONCOLOGY
- New insights to the MLL recombinome of acute leukemias
- (2009) C Meyer et al. LEUKEMIA
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
- (2008) B. V. Balgobind et al. BLOOD
- MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
- (2008) R. Garzon et al. BLOOD
- MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
- (2008) M. Jongen-Lavrencic et al. BLOOD
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
- (2008) I H I M Hollink et al. LEUKEMIA
- Acute Leukemias in Children with Down Syndrome
- (2008) C. Michel Zwaan et al. PEDIATRIC CLINICS OF NORTH AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More